Second primary B-ALL after exposure to lenalidomide for multiple myeloma: A US multicenter study.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Arjun Lakshman, Jeffrey Lee Jensen, Rajshekhar Chakraborty, Gene Shaw, Dragan Jevremovic, Min Shi, James R Cook, Sara A Monaghan, Jithma P. Abeykoon, Ricardo Parrondo, Peter Leif Bergsagel, Mounzer E. Agha, Sam Rubinstein, Catherine Callaghan Coombs, Sawa Ito, Mithun Vinod Shah, Anjali S. Advani, Linda Baughn, Shaji Kumar
Institutions: University of North Carolina at Chapel Hill, Columbia University Irving Medical Center, Marshfield Clinic, Mayo Clinic, Cleveland Clinic, University of Pittsburgh, Mayo Clinic in Florida, Mayo Clinic in Arizona, UPMC Hillman Cancer Center, UNC Lineberger Comprehensive Cancer Center, University of California, Irvine
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4399480733